NZ203117A - Nasally applied pharmaceutical compositions - Google Patents

Nasally applied pharmaceutical compositions

Info

Publication number
NZ203117A
NZ203117A NZ203117A NZ20311783A NZ203117A NZ 203117 A NZ203117 A NZ 203117A NZ 203117 A NZ203117 A NZ 203117A NZ 20311783 A NZ20311783 A NZ 20311783A NZ 203117 A NZ203117 A NZ 203117A
Authority
NZ
New Zealand
Prior art keywords
composition according
agent
nasal
composition
active agent
Prior art date
Application number
NZ203117A
Other languages
English (en)
Inventor
J-R Kiechel
F Aczat-Mispelter
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ203117A publication Critical patent/NZ203117A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ203117A 1982-02-01 1983-01-28 Nasally applied pharmaceutical compositions NZ203117A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (1)

Publication Number Publication Date
NZ203117A true NZ203117A (en) 1986-12-05

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ203117A NZ203117A (en) 1982-02-01 1983-01-28 Nasally applied pharmaceutical compositions

Country Status (27)

Country Link
JP (1) JPS58134017A (pt)
AT (1) AT385656B (pt)
AU (1) AU565613B2 (pt)
BE (1) BE895750A (pt)
CA (1) CA1197783A (pt)
CH (1) CH653555A5 (pt)
DE (1) DE3302949A1 (pt)
DK (1) DK164771C (pt)
ES (1) ES519450A0 (pt)
FI (1) FI81258C (pt)
FR (1) FR2539994B1 (pt)
GR (1) GR81320B (pt)
HK (1) HK59989A (pt)
HU (1) HU191512B (pt)
IE (1) IE54532B1 (pt)
IL (1) IL67822A (pt)
IT (1) IT1197558B (pt)
KE (1) KE3888A (pt)
LU (1) LU84613A1 (pt)
MY (1) MY8700766A (pt)
NL (1) NL192325C (pt)
NZ (1) NZ203117A (pt)
PH (1) PH22198A (pt)
PT (1) PT76166B (pt)
SE (1) SE454402B (pt)
SG (1) SG34389G (pt)
ZA (1) ZA83673B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
KR20200118032A (ko) * 2018-01-05 2020-10-14 임펠 뉴로파마 인코포레이티드 정밀 후각기관 장치에 의한 디하이드로에르고타민의 비강내 전달

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
ES8502865A1 (es) 1985-02-01
DK164771B (da) 1992-08-17
JPH0253406B2 (pt) 1990-11-16
NL8300325A (nl) 1983-09-01
ES519450A0 (es) 1985-02-01
SE454402B (sv) 1988-05-02
BE895750A (fr) 1983-08-01
PT76166A (en) 1983-02-01
ATA30383A (de) 1987-10-15
FI81258B (fi) 1990-06-29
DK38183A (da) 1983-08-02
IL67822A (en) 1988-02-29
IL67822A0 (en) 1983-06-15
FR2539994B1 (fr) 1986-10-10
AT385656B (de) 1988-05-10
GR81320B (pt) 1984-12-11
AU1085083A (en) 1983-08-11
CA1197783A (en) 1985-12-10
IE54532B1 (en) 1989-11-08
LU84613A1 (fr) 1983-09-08
MY8700766A (en) 1987-12-31
IE830187L (en) 1983-08-01
SE8300495L (sv) 1983-08-02
DE3302949A1 (de) 1983-08-11
FI830245L (fi) 1983-08-02
HK59989A (en) 1989-08-04
FI830245A0 (fi) 1983-01-25
DE3302949C2 (pt) 1992-05-21
DK164771C (da) 1992-12-28
SE8300495D0 (sv) 1983-01-31
CH653555A5 (de) 1986-01-15
PH22198A (en) 1988-06-28
HU191512B (en) 1987-02-27
NL192325B (nl) 1997-02-03
FR2539994A1 (fr) 1984-08-03
IT8347646A0 (it) 1983-02-01
IT1197558B (it) 1988-12-06
SG34389G (en) 1989-09-22
FI81258C (fi) 1990-10-10
KE3888A (en) 1989-09-01
AU565613B2 (en) 1987-09-24
JPS58134017A (ja) 1983-08-10
NL192325C (nl) 1997-06-04
DK38183D0 (da) 1983-01-31

Similar Documents

Publication Publication Date Title
US5169849A (en) Nasal pharmaceutical compositions
EP0760649B1 (en) Fluticasone propionate formulations
US4556557A (en) Method and composition for combating snoring, and the use of surface active substances for the preparation of said composition
RU2421209C2 (ru) Фармацевтические композиции, содержащие циклоспорин
JP3830158B2 (ja) 禁煙補助組成物
US5801161A (en) Pharmaceutical composition for the intranasal administration of hydroxocobalamin
ES2395130T3 (es) Método y composición para el tratamiento de rinitis
CA2581209A1 (en) Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
PT999841E (pt) Composicoes farmaceuticas contendo hemissulfato de eletriptano
KR20190055057A (ko) 알코올 사용 장애의 치료용 조성물, 장치 및 방법
SK12682003A3 (sk) Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu
US4885305A (en) Nasal compositions
JPH02196716A (ja) 薬学的溶液
GB2114001A (en) Nasal pharmaceutical compositions
NZ203117A (en) Nasally applied pharmaceutical compositions
WO1996000071A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine
ES2398576T3 (es) Tratamiento agudo de la fobia social con un esteroide androsta-4,16-dien-3-ol
AU2021382051A1 (en) Imatinib formulations, manufacture, and uses thereof